Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240031 | 12524003 | 1 | I | 20151008 | 20151222 | 20160704 | 20160704 | PER | US-JAZZ-2015-US-022397 | JAZZ | 48.87 | YR | M | Y | 0.00000 | 20160704 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125240031 | 12524003 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 125240031 | 12524003 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 125240031 | 12524003 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 125240031 | 12524003 | 4 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 5 | C | BACLOFEN. | BACLOFEN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 6 | C | Calcium + vitamin d | CALCIUMVITAMIN D | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 7 | C | CELEBREX | CELECOXIB | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125240031 | 12524003 | 8 | C | Fish oil concentrate | 2 | UNK | U | 0 | |||||||||||
| 125240031 | 12524003 | 9 | C | Multivitamins | VITAMINS | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 10 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 12 | C | SULFASALAZINE. | SULFASALAZINE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 13 | C | NUVIGIL | ARMODAFINIL | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 14 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | UNK | U | 0 | TABLET | |||||||||
| 125240031 | 12524003 | 15 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 0 | INHALER | |||||||||
| 125240031 | 12524003 | 16 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125240031 | 12524003 | 17 | C | Glucosamine + chondroitin | 2 | UNK | U | 0 | CAPSULE | ||||||||||
| 125240031 | 12524003 | 18 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 125240031 | 12524003 | 19 | C | CLARITIN | LORATADINE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 20 | C | DARVOCET | ACETAMINOPHENPROPOXYPHENE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 21 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 22 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 23 | C | EMBELINE | CLOBETASOL PROPIONATE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 24 | C | ENTEX T | GUAIFENESINPSEUDOEPHEDRINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 25 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 26 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 27 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 28 | C | PARAFON FORTE | CHLORZOXAZONE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 29 | C | RANITIDINE. | RANITIDINE | 1 | UNK | U | 0 | ||||||||||
| 125240031 | 12524003 | 30 | C | SKELAXIN | METAXALONE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125240031 | 12524003 | 1 | Narcolepsy |
| 125240031 | 12524003 | 4 | Product used for unknown indication |
| 125240031 | 12524003 | 5 | Product used for unknown indication |
| 125240031 | 12524003 | 6 | Product used for unknown indication |
| 125240031 | 12524003 | 7 | Product used for unknown indication |
| 125240031 | 12524003 | 8 | Product used for unknown indication |
| 125240031 | 12524003 | 9 | Product used for unknown indication |
| 125240031 | 12524003 | 10 | Product used for unknown indication |
| 125240031 | 12524003 | 11 | Product used for unknown indication |
| 125240031 | 12524003 | 12 | Product used for unknown indication |
| 125240031 | 12524003 | 13 | Product used for unknown indication |
| 125240031 | 12524003 | 14 | Product used for unknown indication |
| 125240031 | 12524003 | 15 | Product used for unknown indication |
| 125240031 | 12524003 | 16 | Product used for unknown indication |
| 125240031 | 12524003 | 17 | Product used for unknown indication |
| 125240031 | 12524003 | 18 | Product used for unknown indication |
| 125240031 | 12524003 | 19 | Product used for unknown indication |
| 125240031 | 12524003 | 20 | Product used for unknown indication |
| 125240031 | 12524003 | 21 | Product used for unknown indication |
| 125240031 | 12524003 | 22 | Product used for unknown indication |
| 125240031 | 12524003 | 23 | Product used for unknown indication |
| 125240031 | 12524003 | 24 | Product used for unknown indication |
| 125240031 | 12524003 | 25 | Product used for unknown indication |
| 125240031 | 12524003 | 26 | Product used for unknown indication |
| 125240031 | 12524003 | 27 | Product used for unknown indication |
| 125240031 | 12524003 | 28 | Product used for unknown indication |
| 125240031 | 12524003 | 29 | Product used for unknown indication |
| 125240031 | 12524003 | 30 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125240031 | 12524003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125240031 | 12524003 | Carpal tunnel syndrome | |
| 125240031 | 12524003 | Condition aggravated | |
| 125240031 | 12524003 | Intentional product use issue | |
| 125240031 | 12524003 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125240031 | 12524003 | 1 | 200602 | 200603 | 0 | |
| 125240031 | 12524003 | 3 | 201201 | 0 | ||
| 125240031 | 12524003 | 4 | 20140930 | 20151222 | 0 | |
| 125240031 | 12524003 | 5 | 20140930 | 0 | ||
| 125240031 | 12524003 | 6 | 20140930 | 0 | ||
| 125240031 | 12524003 | 7 | 20140930 | 0 | ||
| 125240031 | 12524003 | 8 | 20140930 | 0 | ||
| 125240031 | 12524003 | 9 | 20140930 | 0 | ||
| 125240031 | 12524003 | 10 | 20140930 | 0 | ||
| 125240031 | 12524003 | 11 | 20140930 | 0 | ||
| 125240031 | 12524003 | 12 | 20121205 | 20151222 | 0 | |
| 125240031 | 12524003 | 13 | 20100629 | 20151222 | 0 | |
| 125240031 | 12524003 | 14 | 20100330 | 0 | ||
| 125240031 | 12524003 | 15 | 20100330 | 20151222 | 0 | |
| 125240031 | 12524003 | 16 | 20100330 | 0 | ||
| 125240031 | 12524003 | 17 | 20100330 | 0 | ||
| 125240031 | 12524003 | 18 | 20100330 | 0 | ||
| 125240031 | 12524003 | 19 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 20 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 21 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 22 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 23 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 24 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 25 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 26 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 27 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 28 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 29 | 20010101 | 20151222 | 0 | |
| 125240031 | 12524003 | 30 | 20010101 | 20151222 | 0 |